{"DataElement":{"publicId":"2180748","version":"1","preferredName":"Hematopoietic Lymphoma International Classification Type","preferredDefinition":"the REAL classification of lymphoma disease in a patient using standard criteria from the Revised European and Amercian Classification system.","longName":"HEM_LYMP_INT_CLAS_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195898","version":"1","preferredName":"Hematopoietic Lymphoma International Classification","preferredDefinition":"information related to the hematopoietic lymphoma international classification.","longName":"HEM_LYMPH_INTL_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206907","version":"1","preferredName":"Hematopoietic Lymphoma","preferredDefinition":"Pertaining to or related to the formation of blood cells.:A malignant (clonal) proliferation of B- or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites.  This category includes Non-Hodgkin's lymphomas and Hodgkin's lymphomas. -- 2003","longName":"C13324:C3208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic","conceptCode":"C13324","definition":"Pertaining to or related to the formation of blood cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0EBE-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207695","version":"1","preferredName":"International Classification","preferredDefinition":"Concerning or belonging to two or more nations.:Classification; the grouping of things into classes or categories.","longName":"C25541:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International","conceptCode":"C25541","definition":"Concerning or belonging to two or more nations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2CDE-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDF6D030-0828-6EAF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2180747","version":"1","preferredName":"Lymphoma International Classification Type","preferredDefinition":"information related to the international diagnosis type for lymphoma.","longName":"LYMPH_INTL_CLASS_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"125","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"lymphocyte predominance","valueDescription":"lymphocyte predominance","ValueMeaning":{"publicId":"2568270","version":"1","preferredName":"lymphocyte predominance","longName":"2568270","preferredDefinition":"lymphocyte predominance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7BB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D2240E5E-A72A-0BA2-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"nodular sclerosis","valueDescription":"nodular sclerosis","ValueMeaning":{"publicId":"2568271","version":"1","preferredName":"nodular sclerosis","longName":"2568271","preferredDefinition":"nodular sclerosis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7BC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D2240E5E-A72E-0BA2-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"mixed cellularity","valueDescription":"mixed cellularity","ValueMeaning":{"publicId":"2568272","version":"1","preferredName":"mixed cellularity","longName":"2568272v1.00","preferredDefinition":"A subtype of classic Hodgkin lymphoma with scattered Reed-Sternberg and Hodgkin cells in a diffuse or vaguely nodular mixed inflammatory background without nodular sclerosing fibrosis. (WHO, 2008)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Cellularity Classic Hodgkin Lymphoma","conceptCode":"C3517","definition":"A subtype of classic Hodgkin lymphoma with scattered Reed-Sternberg and Hodgkin cells in a diffuse or vaguely nodular mixed inflammatory background without nodular sclerosing fibrosis. (WHO, 2008)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7BD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D2240E5E-A732-0BA2-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"lymphocyte depletion","valueDescription":"lymphocyte depletion","ValueMeaning":{"publicId":"2568273","version":"1","preferredName":"lymphocyte depletion","longName":"2568273","preferredDefinition":"lymphocyte depletion","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphocyte Depletion","conceptCode":"C0024257","definition":"Immunosuppression by reduction of circulating lymphocytes or by T-cell depletion of bone marrow. The former may be accomplished in vivo by thoracic duct drainage or administration of antilymphocyte serum. The latter is performed ex vivo on bone marrow before its transplantation.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7BE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D2240E5E-A736-0BA2-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"lymphocyte-rich classical Hodgkin's disease (provisional category)","valueDescription":"lymphocyte-rich classical Hodgkin's disease (provisional category)","ValueMeaning":{"publicId":"2568274","version":"1","preferredName":"lymphocyte-rich classical Hodgkin's disease (provisional category)","longName":"2568274","preferredDefinition":"lymphocyte-rich classical Hodgkin's disease (provisional category)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7BF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D2240E5E-A73A-0BA2-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"small lymphocytic lymphoma","valueDescription":"small lymphocytic lymphoma","ValueMeaning":{"publicId":"2568275","version":"1","preferredName":"small lymphocytic lymphoma","longName":"2568275","preferredDefinition":"small lymphocytic lymphoma","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Small Lymphocytic Lymphoma","conceptCode":"C7540","definition":"A non-Hodgkin lymphoma composed of monomorphic small, round B-lymphocytes in the lymph nodes.  When the lymphoid process predominantly involves the bone marrow and the peripheral blood it is called chronic lymphocytic leukemia. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7C0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D221D014-A9CE-0359-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"mantle cell lymphoma","valueDescription":"MANTLE CELL LYMPHOMA","ValueMeaning":{"publicId":"2559149","version":"1","preferredName":"MANTLE CELL LYMPHOMA","longName":"2559149v1.00","preferredDefinition":"A non-Hodgkin lymphoma composed of small to medium sized B-lymphocytes (centrocytes). Most patients present with advanced stage disease with lymphadenopathy, hepatosplenomegaly, and bone marrow involvement. The gastrointestinal tract is the most commonly affected extranodal site by this type of non-Hodgkin lymphoma. The vast majority of cases express the t(11;14)(q13;q32) resulting in the rearrangement of the BCL-1 gene and the overexpression of cyclin D1 mRNA.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mantle Cell Lymphoma","conceptCode":"C4337","definition":"A non-Hodgkin lymphoma composed of small to medium sized B-lymphocytes (centrocytes). Most patients present with advanced stage disease with lymphadenopathy, hepatosplenomegaly, and bone marrow involvement. The gastrointestinal tract is the most commonly affected extranodal site by this type of non-Hodgkin lymphoma. The vast majority of cases express the t(11;14)(q13;q32) resulting in the rearrangement of the BCL-1 gene and the overexpression of cyclin D1 mRNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B41A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D221D014-A9D2-0359-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"follicle center lymphoma-I","valueDescription":"follicle center lymphoma-I","ValueMeaning":{"publicId":"2568276","version":"1","preferredName":"follicle center lymphoma-I","longName":"2568276","preferredDefinition":"follicle center lymphoma-I","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7C1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D221D014-A9D5-0359-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"follicle center lymphoma-II","valueDescription":"follicle center lymphoma-II","ValueMeaning":{"publicId":"2568277","version":"1","preferredName":"follicle center lymphoma-II","longName":"2568277","preferredDefinition":"follicle center lymphoma-II","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7C2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D221D014-A9D9-0359-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"follicle center lymphoma-III","valueDescription":"follicle center lymphoma-III","ValueMeaning":{"publicId":"2568278","version":"1","preferredName":"follicle center lymphoma-III","longName":"2568278","preferredDefinition":"follicle center lymphoma-III","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7C3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D221D014-A9DD-0359-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"diffuse predominantly small cell (provisional)","valueDescription":"diffuse predominantly small cell (provisional)","ValueMeaning":{"publicId":"2568279","version":"1","preferredName":"diffuse predominantly small cell (provisional)","longName":"2568279","preferredDefinition":"diffuse predominantly small cell (provisional)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7C4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D22429FA-70F5-0DEB-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"extranodal marginal zone B-cell lymphoma (low grade B-cell lymphoma of MALT type)","valueDescription":"extranodal marginal zone B-cell lymphoma (low grade B-cell lymphoma of MALT type)","ValueMeaning":{"publicId":"2568280","version":"1","preferredName":"extranodal marginal zone B-cell lymphoma (low grade B-cell lymphoma of MALT type)","longName":"2568280","preferredDefinition":"extranodal marginal zone B-cell lymphoma (low grade B-cell lymphoma of MALT type)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7C5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D22429FA-70F9-0DEB-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"nodal marginal zone B-cell lymphoma (monocytoid B-cell lymphoma) (provisional)","valueDescription":"nodal marginal zone B-cell lymphoma (monocytoid B-cell lymphoma) (provisional)","ValueMeaning":{"publicId":"2568281","version":"1","preferredName":"nodal marginal zone B-cell lymphoma (monocytoid B-cell lymphoma) (provisional)","longName":"2568281","preferredDefinition":"nodal marginal zone B-cell lymphoma (monocytoid B-cell lymphoma) (provisional)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7C6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D22429FA-70FD-0DEB-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"splenic marginal zone B-cell lymphoma (provisional)","valueDescription":"splenic marginal zone B-cell lymphoma (provisional)","ValueMeaning":{"publicId":"2568282","version":"1","preferredName":"splenic marginal zone B-cell lymphoma (provisional)","longName":"2568282","preferredDefinition":"splenic marginal zone B-cell lymphoma (provisional)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7C7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D22429FA-7101-0DEB-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"diffuse large B-cell lymphoma","valueDescription":"DIFFUSE LARGE B-CELL LYMPHOMA","ValueMeaning":{"publicId":"2558624","version":"1","preferredName":"DIFFUSE LARGE B-CELL LYMPHOMA","longName":"2558624v1.00","preferredDefinition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Large B-Cell Lymphoma","conceptCode":"C8851","definition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B20D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D22429FA-7105-0DEB-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"primary mediastinal B-cell lymphoma","valueDescription":"primary mediastinal B-cell lymphoma","ValueMeaning":{"publicId":"2568283","version":"1","preferredName":"primary mediastinal B-cell lymphoma","longName":"2568283","preferredDefinition":"primary mediastinal B-cell lymphoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7C8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D223BCA8-986C-0BA4-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Burkitt's lymphoma","valueDescription":"Burkitt Lymphoma","ValueMeaning":{"publicId":"2568284","version":"1","preferredName":"Burkitt Lymphoma","longName":"2568284","preferredDefinition":"A highly aggressive lymphoma composed of monomorphic medium-sized B-cells with basophilic cytoplasm and numerous mitotic figures.  It is often associated with the presence of Epstein-Barr virus (EBV) and is commonly seen in AIDS patients.  Three morphologic variants are recognized: classical Burkitt's lymphoma, Burkitt's lymphoma with plasmacytoid differentiation, and atypical Burkitt's/Burkitt's-like lymphoma.  All cases express the MYC translocation [t(8;14)]. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Burkitt Lymphoma","conceptCode":"C2912","definition":"A highly aggressive lymphoma composed of monomorphic medium-sized B-cells with basophilic cytoplasm and numerous mitotic figures.  It is often associated with the presence of Epstein-Barr virus (EBV) and is commonly seen in AIDS patients.  Three morphologic variants are recognized: classical Burkitt lymphoma, Burkitt lymphoma with plasmacytoid differentiation, and atypical Burkitt/Burkitt-like lymphoma.  All cases express the MYC translocation [t(8;14)]. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7C9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":"04/13/2011 - tc - Updated with current NCIt name and definition.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D223BCA8-9870-0BA4-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"high grade B-cell lymphoma Burkitt-like (provisional)","valueDescription":"high grade B-cell lymphoma Burkitt-like (provisional)","ValueMeaning":{"publicId":"2568285","version":"1","preferredName":"high grade B-cell lymphoma Burkitt-like (provisional)","longName":"2568285","preferredDefinition":"high grade B-cell lymphoma Burkitt-like (provisional)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7CA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D223BCA8-9874-0BA4-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"precursor T-lymphoblastic lymphoma/leukemia","valueDescription":"precursor T-lymphoblastic lymphoma/leukemia","ValueMeaning":{"publicId":"2568286","version":"1","preferredName":"Precursor T-lymphoblastic lymphoma/leukemia","longName":"2568286v1.00","preferredDefinition":"A neoplasm of lymphoblasts committed to the T-cell lineage, typically composed of small to medium-sized blast cells.  When the neoplasm involves predominantly the bone marrow and the peripheral blood, it is called T acute lymphoblastic leukemia.  When it involves nodal or extranodal sites it is called T lymphoblastic lymphoma. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T Lymphoblastic Leukemia/Lymphoma","conceptCode":"C8694","definition":"A neoplasm of lymphoblasts committed to the T-cell lineage, typically composed of small to medium-sized blast cells.  When the neoplasm involves predominantly the bone marrow and the peripheral blood, it is called T acute lymphoblastic leukemia.  When it involves nodal or extranodal sites it is called T lymphoblastic lymphoma. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7CB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"KUMMEROA","dateModified":"2022-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D223BCA8-9878-0BA4-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T-cell chronic lymphocytic leukemia/prolymphocytic leukemia","valueDescription":"T-cell chronic lymphocytic leukemia/prolymphocytic leukemia","ValueMeaning":{"publicId":"2568287","version":"1","preferredName":"T-cell chronic lymphocytic leukemia/prolymphocytic leukemia","longName":"2568287","preferredDefinition":"T-cell chronic lymphocytic leukemia/prolymphocytic leukemia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7CC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D223BCA8-987C-0BA4-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"mycosis fungoides/Sezary's syndrome","valueDescription":"mycosis fungoides/Sezary's syndrome","ValueMeaning":{"publicId":"2568288","version":"1","preferredName":"mycosis fungoides/Sezary's syndrome","longName":"2568288","preferredDefinition":"mycosis fungoides/Sezary's syndrome","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7CD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D2240E5E-A73E-0BA2-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"peripheral T-cell lymphomas unspecified (including provisional subtype: subcutaneous panniculitic T-cell lymphoma)","valueDescription":"peripheral T-cell lymphomas unspecified (including provisional subtype: subcutaneous panniculitic T-cell lymphoma)","ValueMeaning":{"publicId":"2568289","version":"1","preferredName":"peripheral T-cell lymphomas unspecified (including provisional subtype: subcutaneous panniculitic T-cell lymphoma)","longName":"2568289","preferredDefinition":"peripheral T-cell lymphomas unspecified (including provisional subtype: subcutaneous panniculitic T-cell lymphoma)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7CE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D2240E5E-A742-0BA2-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"hepatosplenic T-cell lymphoma (provisional subtype of peripheral T-cell lymphoma)","valueDescription":"hepatosplenic T-cell lymphoma (provisional subtype of peripheral T-cell lymphoma)","ValueMeaning":{"publicId":"2568290","version":"1","preferredName":"hepatosplenic T-cell lymphoma (provisional subtype of peripheral T-cell lymphoma)","longName":"2568290","preferredDefinition":"hepatosplenic T-cell lymphoma (provisional subtype of peripheral T-cell lymphoma)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7CF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D2240E5E-A746-0BA2-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"angioimmunoblastic T-cell lymphoma","valueDescription":"Angioimmunoblastic T-Cell Lymphoma","ValueMeaning":{"publicId":"2558224","version":"1","preferredName":"Angioimmunoblastic T-Cell Lymphoma","longName":"2558224","preferredDefinition":"A mature T-cell non-Hodgkin lymphoma, characterized by systemic disease and a polymorphous infiltrate involving lymph nodes and extranodal sites.  The clinical course is typically aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type","conceptCode":"C7528","definition":"An aggressive follicular helper T-cell lymphoma affecting lymph nodes and other sites. It is characterized by a polymorphous infiltrate and prominent proliferation of high endothelial venules and follicular dendritic cells. It is associated with EBV infection and affects mainly older adults.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B07D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2016-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D2240E5E-A74A-0BA2-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"angiocentric lymphoma","valueDescription":"angiocentric lymphoma","ValueMeaning":{"publicId":"2568291","version":"1","preferredName":"angiocentric lymphoma","longName":"2568291","preferredDefinition":"angiocentric lymphoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7D0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D2240E5E-A74D-0BA2-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"intestinal T-cell lymphoma (+/-  gluten-sensitive enteropathy)","valueDescription":"intestinal T-cell lymphoma (+/-  gluten-sensitive enteropathy)","ValueMeaning":{"publicId":"2568293","version":"1","preferredName":"intestinal T-cell lymphoma (+/-  gluten-sensitive enteropathy)","longName":"2568293","preferredDefinition":"intestinal T-cell lymphoma (+/-  gluten-sensitive enteropathy)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7D2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D223D6AF-3A4A-12F6-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"adult T-cell lymphoma/leukemia","valueDescription":"adult T-cell lymphoma/leukemia","ValueMeaning":{"publicId":"2568294","version":"1","preferredName":"adult T-cell lymphoma/leukemia","longName":"2568294","preferredDefinition":"adult T-cell lymphoma/leukemia","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adult T-Cell Leukemia/Lymphoma","conceptCode":"C3184","definition":"A peripheral (mature) T-cell neoplasm linked to the human T-cell leukemia virus type 1 (HTLV-1).  Adult T-cell leukemia/lymphoma is endemic in several regions of the world, in particular Japan, the Caribbean, and parts of Central Africa.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7D3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D223D6AF-3A4E-12F6-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"anaplastic large cell lymphoma T- and null-cell types","valueDescription":"anaplastic large cell lymphoma T- and null-cell types","ValueMeaning":{"publicId":"2568295","version":"1","preferredName":"anaplastic large cell lymphoma T- and null-cell types","longName":"2568295","preferredDefinition":"anaplastic large cell lymphoma T- and null-cell types","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7D4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D223D6AF-3A52-12F6-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"unclassifiable","valueDescription":"unclassifiable","ValueMeaning":{"publicId":"2568296","version":"1","preferredName":"unclassifiable","longName":"2568296","preferredDefinition":"unclassifiable","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7D5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D223D6AF-3A56-12F6-E034-0003BA12F5E7","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D223D6AF-3A59-12F6-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2240E5E-A724-0BA2-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"COOPERM","dateModified":"2016-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811913","version":"1","longName":"Lymphoma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811943","version":"1","longName":"Hodgkin's Lymphoma","context":"CTEP"},{"publicId":"2811944","version":"1","longName":"NonHodgkins Lymphoma","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"REAL Lymphoma Classification","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D221DEFB-B245-0357-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"CAMPBELB","dateModified":"2005-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}